Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Petiq Inc (PETQ) USD0.001 A

Sell:$24.64 Buy:$24.68 Change: $0.54 (2.14%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Sell:$24.64
Buy:$24.68
Change: $0.54 (2.14%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Sell:$24.64
Buy:$24.68
Change: $0.54 (2.14%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.

Contact details

Address:
Petiq Llc, 230 E. Riverside Dr.
EAGLE
83616
United States
Telephone:
+1 (208) 9398900
Website:
https://petiq.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PETQ
ISIN:
US71639T1060
Market cap:
$730.75 million
Shares in issue:
29.34 million
Sector:
Health Care Distributors
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • McCord Christensen
    Chairman of the Board, Chief Executive Officer
  • Susan Sholtis
    President
  • John Newland
    Chief Financial Officer
  • Michael Smith
    Executive Vice President - Products
  • R. Michael Herrman
    General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.